Skyward Specialty Insurance Group, Inc. (SKWD)
(Delayed Data from NSDQ)
$47.93 USD
-0.20 (-0.42%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $47.00 -0.93 (-1.94%) 5:46 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SKWD 47.93 -0.20(-0.42%)
Will SKWD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SKWD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SKWD
Down 9.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Skyward (SKWD)
Skyward (SKWD) Reports Q2 Earnings: What Key Metrics Have to Say
SKWD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Skyward Specialty Insurance (SKWD) Beats Q2 Earnings Estimates
Insights Into Skyward (SKWD) Q2: Wall Street Projections for Key Metrics
Ambac Financial Group (AMBC) Expected to Beat Earnings Estimates: Should You Buy?
Other News for SKWD
SKWD Price Target Reduced by Piper Sandler Amid Growth Concerns
Piper Sandler Lowers Price Target for Skyward Specialty (SKWD) to $59 | SKWD Stock News
Skyward Specialty Insurance price target lowered by $10 at Piper Sandler, here's why
Skyward targets profitable growth in agriculture, credit, and A&H amid selective cycle management
Skyward Specialty Insurance Group, Inc. (SKWD) Q2 2025 Earnings Call Transcript